the PROTECT study

about the study

There are many unanswered questions about the process of reducing and stopping psychiatric medicines (commonly referred to as 'tapering') and how best to do it. We think that it is important that future research focuses on the questions that are important to people with lived experience of taking and/or stopping any of these medicines, family members, carers/supporters and healthcare professionals.

The PROTECT study team, in partnership with the James Lind Alliance, has set up this priority setting partnership to identify the Top 10 priorities for future research about reducing and stopping psychiatric medicines. This study could help to change the research agenda which will allow future research to focus on the most important questions. 

For more information about the James Lind Alliance and the methods we are using, go to

Study update

Round 1 of the survey has now closed. Thank you to everyone who participated.

We will post further information on how you can take part in Round 2 of the study in the coming weeks.

Please follow us on Twitter (@TaperSafer) for the latest project updates or email if you would like to be notified when the next round of the study goes live.